ArthroCare ENT: Turbinate Reduction

You are on:

Turbinate Reduction

Coblation Turbinate Reduction

Coblation^® Turbinate Reduction can provide a fast return to normal breathing for your patients with turbinate hypertrophy. Coblation Turbinate Reduction, performed with the ReFlex Ultra^® 45 Wand or the ReFlex Ultra^® PTR Wand is intended for the reduction of hypertrophied (enlarged) turbinates. This procedure uses Coblation-Channeling^® to simultaneously remove and shrink submucosal tissue.

Coblation-Channeling^® is a minimally invasive procedure for treating upper nasal airway obstructive symptoms. The submucosal channeling technique removes and shrinks soft tissue while leaving the mucosal lining virtually undisturbed. The unique action of Coblation technology creates channels by ablating tissue as the Wand is inserted into the turbinate. For tissue shrinkage, a submucosal necrotic lesion is created around the tissue channel.

This dual therapy creates an immediate reduction in nasal airway obstruction. Submucosal lesions are created in 10-15 seconds versus the two or more minutes required for other turbinate reduction procedures. This makes Coblation Turbinate Reduction an ideal procedure for the office or the operating room.

Clinical Information

Bhattacharyya N, Kepnes LJ. Clinical effectiveness of Coblation^® inferior turbinate reduction. Otolaryngol Head Neck Surg. 2003; 129: 365-371.
This study determined the safety and clinical effectiveness of Coblation inferior turbinate reduction for turbinate hypertrophy.

Coblation was found to be safe and effective when used for office-based inferior turbinate reduction. The clinical benefit persisted at 6 months after the procedure.
Back LJ, Hytonen ML, Malmberg HO, Ylikoski JS. Submucosal bipolar radiofrequency thermal ablation of inferior turbinates: a long-term follow-up with subjective and objective assessment. Laryngoscope. 2002; 112: 1806-1812.

This study assessed the efficacy and morbidity of Coblation inferior turbinate reduction in patients with nasal obstruction caused by turbinate hypertrophy.

The use of the Coblation was found to be safe for reducing turbinate volume without altering structure of the nasal mucosa and was associated with minimal discomfort for the patient.
Bhattacharyya N, Kepnes LJ. Bipolar radiofrequency cold ablation turbinate reduction for obstructive inferior turbinate hypertrophy. Oper Techn Otolaryngol Head Neck Surg. 2002; 13 (2): 170-4.

This study determined the safety and long-term clinical effectiveness of Coblation inferior turbinate reduction for turbinate hypertrophy. The authors concluded that Coblation provided an effective modality for treating the obstructive nasal symptoms associated with inferior turbinate hypertrophy.